Eqwal Meise
ActiveSummary
Eqwal Meise has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.91M and a net result of €819k. Equity is growing by ~21.1% per year across the filed fiscal years. Its solvency ranks better than 62% of 8001 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
59
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. A confirmed filing finding caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▼-1
Solvency82▲+16
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days only on tighter terms
Liquidity ample (current ratio 2.28 against 1.68 in 2024; short-term debt: 43.4% and cash: 0% of total assets), and 43.4% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.6%
Return on assets
24.2%
Age of the figures
12 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Filed more than 90 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-09-2026, 133 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filingsDeviation from the deadline
2025
133 d late
2024
26 d late
2023
on the day
2022
2 d early
2021
30 d early
2020
37 d early
2019
56 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
€2.92M
EBIT margin
36.8%
Net result
€819k▼ 12.4%
2024 · €934k
2019: €560k
2020: €849k
2021: €862k
2022: €800k
2023: €870k
2024: €934k
2019 → 2025
Working capital
€1.88M▲ 76.7%
2024 · €1.07M
2019: €-17k
2020: €839k
2021: €858k
2022: €1.67M
2023: €1.03M
2024: €1.07M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€2.92M
Equity€888k-€1.69M▲ 90.1%€1.06M▼ 37.3%€1.09M▲ 3.3%€1.91M▲ 75.0%
Operating result€1.16M-€1.07M▼ 7.9%€1.16M▲ 8.2%€1.15M▼ 0.6%€1.09M▼ 5.7%
Net result€862k-€800k▼ 7.1%€870k▲ 8.7%€934k▲ 7.5%€819k▼ 12.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 6% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.38M
Fixed assets
€27k ▲ 4.2%
Current assets
€3.35M ▲ 27.8%
Equity and liabilities €3.38M
Equity
€1.91M ▲ 75.0%
Debt
€1.47M ▼ 5.7%
Debt's share of the balance-sheet total falls from 58.8% to 43.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€1.10M▼
2024 · €1.16M
Cash flow
€829k▼
2024 · €942k
Current ratio
2.28▲
2024 · 1.68
Quick ratio
2.25▲
2024 · 1.65
Debt to equity
0.77▼
2024 · 1.43
ROE
42.8%▼
2024 · 85.5%
ROA
24.2%▼
2024 · 35.3%
Interest coverage
905.40▲
2024 · 535.21
Debt ≤ 1 year
€1.47M▼
2024 · €1.56M
Income taxes
€293k▼
2024 · €334k
Staff costs
€728k▲
2024 · €651k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€2.65M€3.38M▲
Fixed assets21/28€26k€27k▲
Tangible fixed assets22/27€26k€27k▲
Plant, machinery and equipment23€16k€13k▼
Other tangible fixed assets26€10k€14k▲
Current assets29/58€2.62M€3.35M▲
Stocks and contracts in progress3€47k€47k▼
Stocks30/36€47k€47k▼
Amounts receivable within one year40/41€2.56M€3.30M▲
Trade receivables40€1.05M€1.12M▲
Other amounts receivable41€1.51M€2.18M▲
Cash at bank and in hand54/58€3k€207▼
Deferred charges and accrued income490/1€14k€8k▼
Equity and liabilities
Total equity and liabilities10/49€2.65M€3.38M▲
Equity10/15€1.09M€1.91M▲
Contributions10/11€19k€19k=
Reserves13€992€992=
Distributable reserves133€992€992=
Profit (loss) carried forward14€1.07M€1.89M▲
Amounts payable17/49€1.56M€1.47M▼
Amounts payable within one year42/48€1.56M€1.47M▼
Trade debts44€125k€261k▲
Suppliers440/4€125k€261k▲
Taxes, remuneration and social security45€532k€308k▼
Taxes450/3€407k€158k▼
Remuneration and social security454/9€125k€149k▲
Other amounts payable47/48€900k€900k=
Income statement
Code20242025
Remuneration, social security and pensions62€651k€728k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€10k▲
Other operating charges640/8€3k€7k▲
Gross operating margin9900€1.82M€1.83M▲
Operating profit (loss)9901€1.15M€1.09M▼
Financial income75/76B€118k€27k▼
Recurring financial income75€118k€27k▼
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€1.27M€1.11M▼
Income taxes67/77€334k€293k▼
Profit (loss) for the period9904€934k€819k▼
Profit (loss) for the period to be appropriated9905€934k€819k▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.97M€1.89M▼
Profit (loss) brought forward from the previous period14P€1.04M€1.07M▲
Profit to be distributed694/7€900k-
Return on contributions (dividend)694€900k-
Social balance
Average headcount (FTE)90877.97.4▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 133 days late
2025
26-05
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 26 days late
2024
30-09
Financial
Highest result since 2019net €934k ▲7.5%
Net result €934k, the highest in the series.
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
28-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Liquidity triplescurrent ratio 4.30
Current ratio from 1.60 to 4.30; short-term debt falls from €1.43M to €505k.
30-09
Financial
Equity above €1MEq €1.69M ▲90.1%
4 profitable years in a row build equity to €1.69M.
31-03
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
24-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Liquidity quadruplescurrent ratio 4.25
Current ratio from 0.98 to 4.25; short-term debt falls from €832k to €258k.
31-12
Financial
Equity above €500kEq €877k ▲3119%
2 profitable years in a row build equity to €877k.
05-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
Show earlier events
2019
02-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
26-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
19-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
11 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Meise · 1 establishment unit since 1993
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Nieuwelaan 111860 MeiseGround area
835 m²
Building footprint
169 m²
Volume, LiDAR
935 m³
Parcel 23050F0314/00R003, Flanders · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ORTHO APPLICATIONS
since 19932.062.296.016
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23050F0314/00R003 | Flanders | 835 m² | 1 · 169 m² | 9.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 2 entries · 15,722 EUR awarded · 15,722 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 465 EUR | 465 EUR |
| 2022 | 1 | 15,257 EUR | 15,257 EUR |
Schemes
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Legal Entity Identifier
5493001LB1KSRE90L612
Similar companies · same sector, comparable size
embecta Belgium
BE 0771.280.454
Antwerpen · Eq €1,910,223
ULTIMEDI
BE 0834.340.946
Wingene · Eq €1,901,555
MEDISALE
BE 0432.382.547
Gent · Eq €1,894,657
LifeScan Belgium
BE 0696.820.779
Westerlo · Eq €1,894,170
CREDOPHAR
BE 0849.730.193
Gent · Eq €1,930,520
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 703 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-04-1993
Fiscal year end30-09
Activities, NACEBEL 2025
32500Manufacture of medical and dental instruments and supplies
46460Wholesale of pharmaceutical and medical goods
15120Manufacture of leather and related products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 33 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.